MedTrace Logo

Randomized Trial for Botox Urinary Incontinence

NCT00178191 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2011-10-03

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine how effective Botox is in reducing the amount of urine leaked and which dose of Botox is more effective and safe in those who have urinary urge incontinence.

Conditions

Interventions

OTHER

Bladder diary

3-day bladder diary

OTHER

Questionnaires

Incontinence Quality of Life questionnaires

PROCEDURE

Urodynamics

Urodynamics

OTHER

Pad weight

Pad weight

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH

  • National Institute on Aging (NIA)

    collaborator NIH

  • University of Rochester

    lead OTHER

Principal Investigators

  • Michael K Flynn, MD · University of Rochester

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-06-30
Primary Completion
2008-07-31
Completion
2008-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00178191 on ClinicalTrials.gov